JHS Svendgaard Laboratories
Consumer Goods
JHS NSE
₹7.98 −0.02 (−0.25%)
- P/E
- Not meaningful: loss-making over the last twelve months
Close 4 Nov 2026 ₹7.98 −4.24 −34.7% 1Y
Start ₹12.22
Key Fundamentals
MicrocapPersonal ProductsFMCGPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- −0.84%
- Debt to Equity
- 0.09
- EPS (TTM)
- −₹0.22
- Book Value
- ₹19.98
- Market Cap
- —
- P/E (TTM)
- Not meaningful: loss-making over the last twelve months
- P/B
- 0.40
- ROE
- −1.17%
- Dividend Yield
- 0.00%
- EBITDA
- ₹6.10 Cr
- 52W High
- ₹13.69
- 52W Low
- ₹6.26
- Day Range
- ₹7.70 – ₹8.20
- Volume
- 88,203
Peer Comparison
Fast Moving Consumer Goods › Consumer Goods › Personal Care
| ₹849.00 | 45.38 | ₹86,648 Cr | 6.89 | 1.82% | 16.10% | 18.80% | ₹15,949 Cr | ₹1,914 Cr | |
| ₹395.00 | 35.52 | ₹69,681 Cr | 6.14 | 2.16% | 17.00% | 20.30% | ₹13,552 Cr | ₹1,947 Cr | |
| ₹1,660.70 | 33.17 | ₹45,422 Cr | 27.92 | 1.47% | 82.70% | 108.00% | ₹6,391 Cr | ₹1,362 Cr | |
| ₹336.50 | 329.90 | ₹44,683 Cr | 100.45 | 1.48% | 27.60% | 33.90% | ₹484 Cr | ₹137 Cr | |
| ₹7,527.00 | 36.71 | ₹23,745 Cr | 25.92 | 3.32% | 66.50% | 90.70% | ₹3,176 Cr | ₹668 Cr | |
| ₹6,959.00 | 28.57 | ₹22,555 Cr | 29.98 | 3.61% | 115.00% | 157.00% | ₹4,245 Cr | ₹790 Cr | |
| ₹381.35 | 22.24 | ₹16,773 Cr | 5.69 | 2.62% | 26.20% | 28.10% | ₹3,915 Cr | ₹749 Cr | |
| JHS Svendgaard Laboratories (this company) | ₹7.98 | — | ₹69 Cr | 0.40 | 0.00% | −1.17% | −0.84% | ₹109 Cr | −₹2 Cr |
| Median 8 companies | ₹622.00 | 35.52 | ₹34,214 Cr | 16.41 | 1.99% | 26.90% | 31.00% | ₹4,080 Cr | ₹770 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
39 Weak
Data confidence 93/100
surveillance:ESM1
Category scores
- Quality
- 28
- Poor
- Returns, margins, earnings quality 22% weight
- Valuation
- 39
- Weak
- Cheap vs sector & own history 24% weight
- Growth
- 64
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 41
- Weak
- Solvency, leverage, coverage 9% weight
- Momentum
- 44
- Weak
- Trend strength, vol-adjusted 12% weight
- Ownership
- 47
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company is almost debt free.
- Stock is trading at 0.45 times its book value
Weaknesses
6- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 0.18% over past five years.
- Promoter holding is low: 33.8%
- Company has a low return on equity of -4.77% over last 3 years.
- Earnings include an other income of Rs.2.55 Cr.
- Promoter holding has decreased over last 3 years: -3.88%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 5 | 2 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Neutral
Bearish
2
Neutral
5
Bullish
2
Overall
Strong Bearish
Bearish
12
Neutral
5
Bullish
2
Moving Averages
Strong Bearish
Bearish
10
Neutral
0
Bullish
0
Key readings
- RSI (14)
- 41.02
- Neutral
- MACD (12,26,9)
- −0.30
- Bearish
- SMA (50)
- 8.79
- Bearish
- SMA (200)
- 8.72
- Bearish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +0.20% |
|---|---|
| 5Y | +0.20% |
| 3Y | +6.27% |
| 1Y | +10.87% |
| TTM | +19.43% |
Net profit
| 10Y | Loss narrowed by ₹20 Cr |
|---|---|
| 5Y | Turned to loss |
| 3Y | Loss narrowed by ₹16 Cr |
| 1Y | Loss narrowed by ₹18 Cr |
| TTM | Loss narrowed by ₹16.17 Cr |
Operating cash flow
| 10Y | Outflow narrowed by ₹1 Cr |
|---|---|
| 5Y | Turned negative |
| 3Y | Turned negative |
| 1Y | Outflow narrowed by ₹2 Cr |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −4.06 pp |
|---|---|
| 5Y | +0.96 pp |
| 3Y | +13.53 pp |
| 1Y | +7.29 pp |
| TTM | +7.51 pp |
Revenue by year
| Mar 2017 | ₹104 Cr |
|---|---|
| Mar 2018 | ₹140 Cr |
| Mar 2019 | ₹124 Cr |
| Mar 2020 | ₹139 Cr |
| Mar 2021 | ₹101 Cr |
| Mar 2022 | ₹86.00 Cr |
| Mar 2023 | ₹85.00 Cr |
| Mar 2024 | ₹71.00 Cr |
| Mar 2025 | ₹92.00 Cr |
| Mar 2026 | ₹102 Cr |
Net profit by year
| Mar 2017 | ₹22.00 Cr |
|---|---|
| Mar 2018 | ₹26.00 Cr |
| Mar 2019 | −₹2.00 Cr |
| Mar 2020 | −₹5.00 Cr |
| Mar 2021 | ₹1.00 Cr |
| Mar 2022 | −₹4.00 Cr |
| Mar 2023 | −₹18.00 Cr |
| Mar 2024 | −₹4.00 Cr |
| Mar 2025 | −₹20.00 Cr |
| Mar 2026 | −₹2.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.9 | 18.93 | 14.3 | 21.66 | 24.48 | 19.68 | 22.66 | 25.17 | 23.45 | 22.28 | 23.27 | 32.7 | 30.38 | 21.83 |
| Expenses | 18.02 | 18.52 | 14.36 | 20.82 | 22.51 | 20.52 | 22.41 | 30.55 | 21.79 | 21.37 | 21.6 | 34.34 | 28.31 | 21.32 |
| Operating Profit | −2.12 | 0.41 | −0.06 | 0.84 | 1.97 | −0.84 | 0.25 | −5.38 | 1.66 | 0.91 | 1.67 | −1.64 | 2.07 | 0.51 |
| OPM % | −13.33% | 2.17% | −0.42% | 3.88% | 8.05% | −4.27% | 1.1% | −21.37% | 7.08% | 4.08% | 7.18% | −5.02% | 6.81% | 2.34% |
| Other Income | 0.41 | 0.2 | 2.34 | 1.37 | 0.32 | 0.86 | 0.27 | −1.44 | 1 | 1.14 | 0.59 | 0.73 | 0.09 | 1.24 |
| Interest | 0.13 | 0.1 | 0.11 | 0.13 | 0.12 | 0.11 | 0.13 | 0.21 | 0.16 | 0.2 | 0.28 | 0.22 | 0.28 | 0.32 |
| Depreciation | 1.32 | 1.5 | 1.63 | 1.9 | 1.97 | 1.98 | 1.97 | 2.02 | 1.88 | 1.86 | 1.9 | 1.86 | 1.82 | 1.83 |
| PBT | −3.16 | −0.99 | 0.55 | 0.18 | 0.2 | −2.07 | −1.58 | −9.05 | 0.62 | −0.01 | 0.08 | −2.99 | 0.06 | −0.4 |
| Tax % | −18.35% | −26.26% | 100% | 516.67% | 415% | 398.07% | 15.82% | −23.09% | −69.35% | 1800% | −887.5% | 19.73% | −1716.67% | −227.5% |
| Net Profit | −2.59 | −0.73 | 0.01 | −0.75 | −0.63 | −10.32 | −1.84 | −6.96 | 1.06 | −0.2 | 0.79 | −3.57 | 1.09 | 0.51 |
| EPS (₹) | −0.4 | −0.09 | 0 | −0.1 | −0.08 | −1.21 | −0.21 | −0.81 | 0.12 | −0.02 | 0.09 | −0.41 | 0.12 | — |
Sep 2026: from the results filed on 2 Nov 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 55 | 100 | 104 | 140 | 124 | 139 | 101 | 86 | 85 | 71 | 92 | 102 | 109 |
| Expenses | 59 | 93 | 92 | 126 | 124 | 137 | 99 | 87 | 94 | 72 | 96 | 99 | 106 |
| Operating Profit | −4 | 7 | 12 | 14 | 0 | 2 | 2 | −1 | −9 | −1 | −4 | 3 | 3 |
| OPM % | −7% | 7% | 11% | 10% | 0.1% | 1.2% | 1.9% | −1% | −11% | −1.3% | −4.4% | 2.6% | 2.8% |
| Other Income | −6 | −17 | 0 | 32 | 6 | 3 | 7 | 9 | −7 | 4 | 0 | 3 | 3 |
| Interest | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Depreciation | 12 | 10 | 6 | 7 | 7 | 9 | 7 | 7 | 6 | 6 | 8 | 8 | 7 |
| PBT | −22 | −22 | 5 | 38 | −2 | −6 | 1 | 0 | −23 | −3 | −13 | −2 | −3 |
| Tax % | 0% | 0% | −327% | 32% | −19% | −17% | −39% | 4000% | −24% | 18% | 58% | −16% | — |
| Net Profit | −22 | −22 | 22 | 26 | −2 | −5 | 1 | −4 | −18 | −4 | −20 | −2 | −2 |
| EPS (₹) | −9.2 | −5.76 | 4.98 | 4.29 | −0.11 | −0.33 | 0.19 | −0.62 | 0.62 | −0.52 | −2.31 | −0.22 | −0.22 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 38 | 44 | 61 | 61 | 61 | 64 | 65 | 78 | 78 | 86 | 87 |
| Reserves | 96 | 63 | 90 | 113 | 116 | 117 | 124 | 121 | 95 | 91 | 87 | 87 |
| Borrowings | 19 | 3 | 2 | 2 | 7 | 9 | 7 | 6 | 3 | 5 | 6 | 15 |
| Other Liabilities | 33 | 19 | 19 | 32 | 39 | 55 | 33 | 30 | 52 | 22 | 25 | 27 |
| Total Liabilities | 171 | 122 | 155 | 208 | 223 | 241 | 228 | 222 | 228 | 197 | 204 | 216 |
| Fixed Assets | 108 | 65 | 65 | 71 | 71 | 66 | 63 | 59 | 65 | 90 | 90 | 89 |
| CWIP | 0 | 1 | 1 | 1 | 5 | 7 | 9 | 20 | 9 | 1 | 0 | 4 |
| Investments | 0 | 0 | 1 | 18 | 10 | 6 | 2 | 4 | 3 | 3 | 4 | 5 |
| Other Assets | 63 | 57 | 89 | 118 | 137 | 163 | 154 | 140 | 152 | 102 | 110 | 118 |
| Total Assets | 171 | 122 | 155 | 208 | 223 | 241 | 228 | 222 | 228 | 197 | 204 | 216 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 7 | −4 | −4 | 14 | −11 | 10 | 12 | −9 | 23 | −9 | −5 | −3 |
| Investing | 1 | 1 | −3 | −27 | −7 | −11 | −2 | −5 | 10 | −21 | −20 | −12 |
| Financing | −10 | 4 | 10 | 14 | 13 | 0 | 10 | −2 | −1 | 2 | 23 | 11 |
| Net Cash Flow | −1 | 2 | 3 | 0 | −5 | 0 | 20 | −16 | 32 | −28 | −2 | −3 |
| Free Cash Flow | 9 | −7 | −17 | 3 | −26 | 0 | 5 | −16 | 21 | −33 | −14 | −15 |
| CFO/EBITDA | −189 | −58 | −33 | 119 | −10,000 | 595 | 650 | 1,051 | −257 | 1,001 | 122 | −77 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 167 | 25 | 48 | 111 | 158 | 252 | 213 | 77 | 80 | 66 | 52 | 60 |
| Inventory Days | 94 | 53 | 95 | 65 | 60 | 30 | 97 | 114 | 128 | 176 | 151 | 156 |
| Days Payable | 106 | 67 | 123 | 153 | 134 | 177 | 128 | 130 | 197 | 197 | 140 | 174 |
| Cash Conversion Cycle | 156 | 12 | 19 | 23 | 85 | 105 | 182 | 61 | 11 | 46 | 63 | 42 |
| Working Capital Days | −39 | 58 | 56 | 122 | 173 | 198 | 272 | 217 | 41 | 51 | 47 | 45 |
| ROCE % | −12% | −3% | 5% | 8% | 0% | 4% | 1% | 1% | −2% | −2% | −5% | −1% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view JHS Svendgaard Laboratories insights
66 extracted metrics across FY10–FY27.
Documents
- Q4 FY24 concall · May 2024Transcript PPT
- Q2 FY24 concall · Nov 2023Transcript PPT
- Q4 FY23 concall · Jun 2023Transcript PPT
- Q2 FY23 concall · Nov 2022Transcript PPT
- Q1 FY23 concall · Aug 2022PPT
- General announcements 9 Oct 2026
Frequently Asked Questions about JHS Svendgaard Laboratories
What does JHS Svendgaard Laboratories Ltd do?
Incorporated in 1997, JHS Svendgaard Laboratories Ltd does manufacturing of oral and dental products for national and international brands
Where is JHS Svendgaard Laboratories Ltd (JHS) listed?
JHS Svendgaard Laboratories Ltd trades as JHS on the NSE and under code 532771 on the BSE.
Which sector does JHS Svendgaard Laboratories Ltd belong to?
JHS Svendgaard Laboratories Ltd is classified under the Consumer Goods sector, in the Personal Care industry.
What is the 52-week high and low of JHS Svendgaard Laboratories Ltd?
Over the last 52 weeks JHS Svendgaard Laboratories Ltd has traded between ₹6.26 and ₹13.69 as of 4 Nov 2026.
What is the Return on Equity (ROE) of JHS Svendgaard Laboratories Ltd?
JHS Svendgaard Laboratories Ltd reported a return on equity of -1.17%. Its debt-to-equity ratio is 0.09.
Company Information
Incorporated in 1997, JHS Svendgaard Laboratories Ltd does manufacturing of oral and dental products for national and international brands
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/JHS.md for JHS Svendgaard Laboratories Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.